Zobrazeno 1 - 10
of 48
pro vyhledávání: '"M. N Starovoitova"'
Autor:
R. U. Shayakhmetova, L. P. Ananyeva, O. A. Koneva, M. N Starovoitova, O. V. Desinova, O. B. Ovsyannikova, L. A. Garzanova
Publikováno v:
Современная ревматология, Vol 14, Iss 1, Pp 49-56 (2020)
In anti-U1-ribonucleoprotein (anti-U1-RNP) antibody positive patients with systemic scleroderma (SSD), the clinical picture and course of the disease have specific features: there is a preponderance of its limited form; inflammatory damage to the joi
Externí odkaz:
https://doaj.org/article/d8c78c75aa6542c1b2a396e80c6268f8
Autor:
M. N. Starovoitova, O. V. Desinova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, O. B. Ovsyannikova, R. U. Shayakhmetova
Publikováno v:
Современная ревматология, Vol 17, Iss 5, Pp 53-60 (2023)
In systemic sclersis (SSc), different types of renal involvement occur. Their severity can range from asymptomatic deterioration of renal function to life-threatening damage, which is a complex therapeutic problem. Rituximab (RTM) has been used in th
Externí odkaz:
https://doaj.org/article/5c9f566b36bd4479822c02a33d3e7a38
Autor:
A. O. Efremova, N. V. Toroptsova, O. V. Dobrovolskaya, M. N. Starovoitova, O. V. Desinova, O. A. Nikitinskaya
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 5, Pp 592-598 (2021)
Aim of the research – to determine the frequency of osteoporosis (OP) and to identify risk factors for a decrease in bone mineral density (BMD) in postmenopausal women with systemic sclerosis (SSс).Subjects and methods. The study included 113 post
Externí odkaz:
https://doaj.org/article/08e309d945db4fc9ae2a5e8f0aa0e99d
Autor:
R. U. Shayakhmetova, L. P. Ananyeva, M. N. Starovoitova, O. V. Desinova, O. A. Koneva, O. B. Ovsyannikova, L. A. Garzanova, M. V. Cherkasova, R. T. Alekperov
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 1, Pp 48-54 (2020)
Various clinical and immunological phenotypes of systemic sclerosis (SS) differ in the frequency and severity of manifestations of the disease, the progression of damage to internal organs, and prognosis. The detection rate of anti-U1-ribonucleoprote
Externí odkaz:
https://doaj.org/article/56c9458eb80046748424290ef5553d6f
Autor:
R. U. Shayakhmetova, L. P. Ananyeva, O. A. Koneva, M. N. Starovoitova, O. V. Desinova, O. B. Ovsyannikova, L. A. Garzanova
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 5, Pp 539-544 (2019)
Among the patients fulfilling the criteria for systemic sclerosis (SS), there is a subgroup without SS-specific antinuclear antibodies, but positive for anti-ribonucleoprotein (anti-U1 RNP) antibodies. The clinical significance of this type of antinu
Externí odkaz:
https://doaj.org/article/6359d0bff2344c629f0a39c3be43d122
Autor:
L. P. Ananyeva, O. A. Koneva, O. V. Desinova, L. A. Garzanova, S. I. Glukhova, M. N. Starovoitova, O. B. Ovsyannikova, A. V. Volkov, A. P. Aleksankin, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 3, Pp 265-273 (2019)
The choice of drugs for the treatment of interstitial lung disease (ILD) associated with systemic sclerosis (SS) is currently very limited. Data from a number of studies show that rituximab (RTM) can improve lung function and reduce the severity of s
Externí odkaz:
https://doaj.org/article/fb2372c816e44d50a10380459139c10a
Autor:
M. N. Starovoitova, O. V. Desinova
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 6, Pp 777-781 (2019)
As of now, there are several pharmacological directions in the treatment and prevention of Raynaud’s syndrome and digital ulcers, including various vasoactive drugs (calcium channel blockers, intravenous prostanoids, endothelin receptor antagonists
Externí odkaz:
https://doaj.org/article/dd912c711e4349fb9993340db3da12d9
Autor:
M. Yu. Krylov, L. P. Ananyeva, O. A. Koneva, M. N. Starovoitova, E. Yu. Samarkina, O. V. Desinova, O. B. Ovsyannikova, E. N. Aleksandrova, A. A. Novikov, I. A. Guseva
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 1, Pp 37-40 (2017)
The FAS antigen (Apo-1/CD95) is a key molecule of apoptosis in most cell types, including activated immune cells and fibroblasts. The FAS gene promoter region contains a single-nucleotide polymorphism (-670A/G) associated with a substitution of the n
Externí odkaz:
https://doaj.org/article/8b74491bd30c4e2aa5e61a38fc9bf40c
Autor:
M. N. Starovoitova, O. V. Desinova, O. A. Koneva, O. B. Ovsyannikova, R. T. Alekperov, M. V. Cherkasova, E. N. Aleksandrova, L. P. Ananyeva
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 4, Pp 418-423 (2016)
Objective: to estimate frequency of autoantibodies in a cohort of Russian patients with systemic sclerosis (SS) and to investigate clinical associations of these autoantibodies.Subjects and methods. In 2012 to 2015, the investigation enrolled 300 pat
Externí odkaz:
https://doaj.org/article/9a947e073851441d9b0cef4c38421482
Autor:
O. B. Ovsyannikova, L. P. Ananyeva, V. N. Lesnyak, O. A. Koneva, M. N. Starovoitova, O. V. Desinova
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 3, Pp 312-317 (2016)
Systemic sclerosis (SS) is a systemic disease, the basis for which is microcirculatory disorders, inflammation, and generalized fibrosis. Interstitial lung disease (ILD) is one of the primary manifestations of SS. Assessment of SS activity and severi
Externí odkaz:
https://doaj.org/article/26dec4ac064d45e89534adc41f4d096a